Jefferies downgraded PeptiDream to Hold from Buy with a price target of 1,900 yen, down from 2,200 yen. The firm has become “more optimistic” about radiopharma revenues, but “less optimistic” about margins, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>